Adingupu DD, Gopel SO, Gronros J, Behrendt M, Sotak M, Miliotis T et al (2019) SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob(-/-) mice. Cardiovasc Diabetol 18(1):16

PubMed  PubMed Central  Google Scholar 

Andrew Rhodes LEE, Alhazzani Waleed, Levy Mitchell M, Antonelli Massimo, Ferrer Ricard, Kumar Anand, Sevransky Jonathan E, Sprung Charles L, Nunnally Mark E, Rochwerg Bram, Rubenfeld Gordon D, Angus DC, Annane Djillali, Beale Richard J, Bellinghan Geoffrey J, Bernard Gordon R, Chiche Jean-Daniel, Coopersmith Craig, De Backer Daniel P, French Craig J, Fujishima Seitaro, Gerlach Herwig, Hidalgo Jorge Luis, Hollenberg Steven M, Jones Alan E, Karnad Dilip R, Kleinpell RM, Koh Younsuk, Lisboa Thiago Costa, Machado Flavia R, Marini John J, Marshal JC, Mazuski John E, McIntyre Lauralyn A, McLean Anthony S, Mehta Sangeeta, Moreno Rui P, Myburgh John, Navalesi Paolo, Nishida Osamu, Osborn Tiffany M, Perner Anders, Plunkett Colleen M, Ranieri Marco, Schorr Christa A, Seckel Maureen A, Seymour Christopher W, Shieh Lisa, Shukri Khalid A, Simpson Steven Q, Singer Mervyn, Taylor Thompson B, Townsend SR, Van der Poll Thomas, Jean-Louis Vincent W, Wiersinga Joost, Zimmerman Janice L, Phillip Dellinger R (2016) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43:304–377

Google Scholar 

Bajic VP, Van Neste C, Obradovic M, Zafirovic S, Radak D, Bajic VB et al (2019) Glutathione “Redox Homeostasis” and Its Relation to Cardiovascular Disease. Oxid Med Cell Longev 2019:5028181

PubMed  PubMed Central  Google Scholar 

Belch JJ, Bridges AB, Scott N, Chopra M (1991) Oxygen free radicals and congestive heart failure. Br Heart J 65(5):245–248

CAS  PubMed  PubMed Central  Google Scholar 

Chen YR, Zweier JL (2014) Cardiac mitochondria and reactive oxygen species generation. Circ Res 114(3):524–537

CAS  PubMed  PubMed Central  Google Scholar 

Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X et al (2023) Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition. Front Pharmacol 14:1078205

CAS  PubMed  PubMed Central  Google Scholar 

Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiol Rev 99(4):1765–1817

PubMed  PubMed Central  Google Scholar 

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072

CAS  PubMed  PubMed Central  Google Scholar 

Fang X, Wang H, Han D, Xie E, Yang X, Wei J et al (2019) Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA 116(7):2672–2680

CAS  PubMed  PubMed Central  Google Scholar 

Fang X, Ardehali H, Min J, Wang F (2023) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol 20(1):7–23

PubMed  Google Scholar 

Furtado RHM, Bonaca MP, Raz I, Zelniker TA, Mosenzon O, Cahn A et al (2019) Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction. Circulation 139(22):2516–2527

CAS  PubMed  Google Scholar 

Han X, Liu X, Zhao X, Wang X, Sun Y, Qu C et al (2023) Dapagliflozin ameliorates sepsis-induced heart injury by inhibiting cardiomyocyte apoptosis and electrical remodeling through the PI3K/Akt pathway. Eur J Pharmacol 955:175930

CAS  PubMed  Google Scholar 

Hill MF, Singal PK (1996) Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148(1):291–300

CAS  PubMed  PubMed Central  Google Scholar 

Hill MF, Singal PK (1997) Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96(7):2414–2420

CAS  PubMed  Google Scholar 

Hu J, Xu J, Tan X, Li D, Yao D, Xu B et al (2023) Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation. Naunyn Schmiedebergs Arch Pharmacol 396(7):1461–1470

CAS  PubMed  PubMed Central  Google Scholar 

Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N et al (2020a) Ferroptosis: past, present and future. Cell Death Dis 11(2):88

PubMed  PubMed Central  Google Scholar 

Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C et al (2020b) Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med 160:303–318

CAS  PubMed  Google Scholar 

Li Y, Jiang Y, Zhou W, Wu Y, Zhang S, Ding G et al (2022) Maintaining homeostasis of mitochondria and endoplasmic reticulum with NSC228155 alleviates cisplatin-induced acute kidney injury. Free Radic Biol Med 181:270–287

CAS  PubMed  Google Scholar 

Liesa M, Palacin M, Zorzano A (2009) Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89(3):799–845

CAS  PubMed  Google Scholar 

Lin Y, Xu Y, Zhang Z (2020) Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria. Inflammation 43(4):1184–1200

CAS  PubMed  Google Scholar 

Lin K, Yang N, Luo W, Qian JF, Zhu WW, Ye SJ et al (2022) Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling. Acta Pharmacol Sin 43(10):2624–2635

CAS  PubMed  PubMed Central  Google Scholar 

Liu YC, Yu MM, Shou ST, Chai YF (2017) Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments. Front Immunol 8:1021

PubMed  PubMed Central  Google Scholar 

Lv X, Wang H (2016) Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res 3:30

PubMed  PubMed Central  Google Scholar 

Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97(16):1536–1539

CAS  PubMed  Google Scholar 

Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509(7498):105–109

CAS  PubMed  PubMed Central  Google Scholar 

Mi Y, Wei C, Sun L, Liu H, Zhang J, Luo J et al (2023) Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6/p-Nrf2/GPX4 and SIRT6/NCOA4/FTH1 pathways. Biomed Pharmacother 157:114048

CAS  PubMed  Google Scholar 

Nikolaou PE, Efentakis P, Abu Qourah F, Femmino S, Makridakis M, Kanaki Z et al (2021) Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress. Antioxid Redox Signal 34(7):551–571

CAS  PubMed  Google Scholar 

Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S et al (2022) Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect? Basic Res Cardiol 117(1):27

CAS  PubMed  Google Scholar 

Niu Y, Zhang Y, Zhang W, Lu J, Chen Y, Hao W et al (2022) Canagliflozin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Inhibiting NF-kappaB Signaling and Upregulating Bif-1. Front Pharmacol 13:820541

CAS  PubMed  PubMed Central  Google Scholar 

Olgar Y, Turan B (2019) A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn(2+)-transporters in cardiomyocytes from insulin-resistant metabolic syndrome rats through inhibition of oxidative stress (1). Can J Physiol Pharmacol 97(6):528–535

CAS  PubMed  Google Scholar 

Peng S, Xu J, Ruan W, Li S, Xiao F (2017) PPAR-gamma Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and Necroptosis. Oxid Med Cell Longev 2017:8326749

PubMed  PubMed Central  Google Scholar 

Qi Z, Liu R, Ju H, Huang M, Li Z, Li W et al (2023) microRNA-130b-3p Attenuates Septic Cardiomyopathy by Regulating the AMPK/mTOR Signaling Pathways and Directly Targeting ACSL4 against Ferroptosis. Int J Biol Sci 19(13):4223–4241

CAS  PubMed  PubMed Central  Google Scholar 

Ravikumar N, Sayed MA, Poonsuph CJ, Sehgal R, Shirke MM, Harky A (2021) Septic Cardiomyopathy: From Basics to Management Choices. Curr Probl Cardiol 46(4):100767

PubMed  Google Scholar 

Reifsnider, O. S., Kansal, A. R., Gandhi, P. K., Cragin, L., Brand, S. B., Pfarr, E., et al. (2021). Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease. BMJ Open Diabetes Res Care, 9(1).

Rudiger A, Dyson A, Felsmann K, Carre JE, Taylor V, Hughes S et al (2013) Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis. Clin Sci (lond) 124(6):391–401

CAS  PubMed